Manuel Méndez

Gene Therapy of a Mouse Model of Protoporphyria with a Self-Inactivating Erythroid-Specific Lentiviral Vector without Preselection

Emmanuel Richard, Manuel Méndez, Frédéric Mazurier et al. · Molecular Therapy · 2001 · 60 citations · Full text

Blood Disorders, Cell Therapy, Immunology +17

Familial Porphyria Cutanea Tarda: Characterization of Seven Novel Uroporphyrinogen Decarboxylase Mutations and Frequency of Common Hemochromatosis Alleles

Manuel Méndez, Lonnie Sorkin, María Victoria Rossetti et al. · The American Journal of Human Genetics · 1998 · 57 citations · Full text

Biology, Common Hemochromatosis Alleles, Genetic Disorder +7

Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

Jesús Castilla, Manuel Garcìa Cenoz, Raquel Abad et al. · New England Journal of Medicine · 2023 · 55 citations · Full text

The role of inherited and acquired factors in the development of porphyria cutanea tarda in the Argentinean population

Manuel Méndez, María Victoria Rossetti, Alcira Batlle et al. · Journal of the American Academy of Dermatology · 2005 · 46 citations · Full text

Biology, Phylogenetics, Argentinean Population +5

Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells

Antonio Fontanellas, Manuel Méndez, Frédéric Mazurier et al. · Gene Therapy · 2001 · 33 citations

Knockout Mouse, Partial Genetic Correction, Developmental Biology +10